Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.-Reference-Cited by-同舟云学术

Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.

Published:1987-10-10 Issue:6603 Volume:295 Page:873-875
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Dearden C E,Matutes E,Hoffbrand A V,Ganeshaguru K,Brozovic M,Williams H J,Traub N,Mills M,Linch D C,Catovsky D

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference11 articles.

1. Effectiveness of Pentostatin (2' deoxycoformycin) in refractory lymphoid neoplasms;Spiers, A.S.D.; Ruckdeschel, J.C.; Horton, J.;ScandJ Haematol,1984

2. Deoxycoformycin in the treatment of leukemias and lymphomas;Smyth, J.F.; Prentice, H.G.; Proctor, S.; Hoffbrand, A.V.;AnnNYAcad Sci,1986

3. Remissions'in hairy-cell leukemia with Pentostatin (2' deoxycoformycin);Spiers, A.S.D.; Moore, D.; Cassileth, P.A.;N Engl Med,1987

4. Low-dose deoxycoformycin in lymphoid malignancy;Grever, M.R.; Leiby, J.M.; Kraut, E.H.;Journal ofClinical Oncology,1985

5. The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy;Grever, M.R.; Siaw, M.F.E.; Jacob, W.F.;Blood,1981

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chlorambucil and prednisolone therapy in a patient with T-cell chronic lymphocytic leukaemia;Clinical & Laboratory Haematology;1996-06

2. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.;Journal of Clinical Oncology;1994-12

3. Promace day 1/MOPP day 8 chemotherapy for prolymphocytic leukemia: A case report of prolonged survival;American Journal of Hematology;1994-07

4. Pentostatin;Drugs;1993-10

5. Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2′-deoxycoformycin;Leukemia Research;1992-08